Altamira Therapeutics Stock Market Value
| CYTO Stock | USD 0.44 0.03 7.32% |
| Symbol | Altamira |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altamira Therapeutics. If investors know Altamira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altamira Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Altamira Therapeutics is measured differently than its book value, which is the value of Altamira that is recorded on the company's balance sheet. Investors also form their own opinion of Altamira Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Altamira Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altamira Therapeutics' market value can be influenced by many factors that don't directly affect Altamira Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altamira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Altamira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altamira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Altamira Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Altamira Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Altamira Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Altamira Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Altamira Therapeutics or generate 0.0% return on investment in Altamira Therapeutics over 30 days. Altamira Therapeutics is related to or competes with Pyxis Oncology, Zura Bio, Elevation Oncology, Immix Biopharma, Enveric Biosciences, Palisade Bio, and Cns Pharmaceuticals. Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs More
Altamira Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Altamira Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Altamira Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 22.81 | |||
| Value At Risk | (10.87) | |||
| Potential Upside | 6.98 |
Altamira Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Altamira Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Altamira Therapeutics' standard deviation. In reality, there are many statistical measures that can use Altamira Therapeutics historical prices to predict the future Altamira Therapeutics' volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.64) | |||
| Treynor Ratio | 6.04 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Altamira Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Altamira Therapeutics Backtested Returns
Altamira Therapeutics secures Sharpe Ratio (or Efficiency) of -0.22, which signifies that the company had a -0.22% return per unit of risk over the last 3 months. Altamira Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Altamira Therapeutics' Mean Deviation of 3.49, standard deviation of 4.72, and Risk Adjusted Performance of (0.16) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Altamira Therapeutics are expected to decrease at a much lower rate. During the bear market, Altamira Therapeutics is likely to outperform the market. At this point, Altamira Therapeutics has a negative expected return of -1.02%. Please make sure to confirm Altamira Therapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Altamira Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Altamira Therapeutics has average predictability. Overlapping area represents the amount of predictability between Altamira Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Altamira Therapeutics price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Altamira Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Altamira Therapeutics lagged returns against current returns
Autocorrelation, which is Altamira Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Altamira Therapeutics' stock expected returns. We can calculate the autocorrelation of Altamira Therapeutics returns to help us make a trade decision. For example, suppose you find that Altamira Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Altamira Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Altamira Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Altamira Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Altamira Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Altamira Therapeutics Lagged Returns
When evaluating Altamira Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Altamira Therapeutics stock have on its future price. Altamira Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Altamira Therapeutics autocorrelation shows the relationship between Altamira Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Altamira Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Altamira Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altamira Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Altamira Stock
| 0.76 | VALN | Valneva SE ADR Downward Rally | PairCorr |
Moving against Altamira Stock
| 0.73 | VCYT | Veracyte | PairCorr |
| 0.71 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.7 | VERA | Vera Therapeutics | PairCorr |
| 0.55 | VAXX | Vaxxinity | PairCorr |
| 0.55 | SABSW | SAB Biotherapeutics | PairCorr |
The ability to find closely correlated positions to Altamira Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Altamira Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Altamira Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Altamira Therapeutics to buy it.
The correlation of Altamira Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altamira Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altamira Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Altamira Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Altamira Therapeutics Correlation, Altamira Therapeutics Volatility and Altamira Therapeutics Alpha and Beta module to complement your research on Altamira Therapeutics. To learn how to invest in Altamira Stock, please use our How to Invest in Altamira Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Altamira Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.